---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-038470"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2024-08-26T23:59:59+00:00"
generated_at: "2026-05-31T07:33:53.814617+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# STRATA Skin Sciences sues LaserOptek, MLS, Pinnacle for false advertising of Pallas lasers

## Summary
- Filed complaint in U.S. District Court for Eastern District of Pennsylvania alleging unfair competition and false advertising under Lanham Act.
- Claims defendants misrepresented that Pallas lasers qualify for CMS reimbursement codes reserved for excimer lasers like STRATA's XTRAC.
- Also alleges false statements of technological and clinical equivalence without scientific evidence, causing harm to competition and patients.
- Seeks injunctive relief, actual and treble damages, disgorgement of profits, and legal costs from LaserOptek, MLS, and Pinnacle.
- Defendants include Korean manufacturer LaserOptek (KOSDAQ), its U.S. distributor Monarch Laser Services, and advisor Pinnacle Health Group.

## SEC filing metadata
- accession: 0001140361-24-038470
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2024-08-26T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036124038470/0001140361-24-038470-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036124038470/ef20034698_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-038470
- JSON: https://secwatch.observer/filing/0001140361-24-038470.json
- Plain text: https://secwatch.observer/filing/0001140361-24-038470.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.